107 related articles for article (PubMed ID: 12782336)
1. Two clusters of serum midkine levels in drug-naive patients with schizophrenia.
Shimizu E; Hashimoto K; Salama RH; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Nakazato M; Kumakiri C; Okada S; Muramatsu H; Muramatsu T; Iyo M
Neurosci Lett; 2003 Jun; 344(2):95-8. PubMed ID: 12782336
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Tagawa M; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
Cancer Sci; 2003 Jul; 94(7):628-32. PubMed ID: 12841873
[TBL] [Abstract][Full Text] [Related]
3. Increased serum midkine levels during hemodialysis using heparin in chronic renal failure.
Fujisawa K; Matsumoto Y; Muramatsu H; Shinzato T; Hiramatsu K; Horie K; Cai Z; Oka H; Amano I; Muramatsu T; Maeda K
J Biochem; 1998 May; 123(5):864-9. PubMed ID: 9562618
[TBL] [Abstract][Full Text] [Related]
4. Serum midkine levels are increased in patients with various types of carcinomas.
Ikematsu S; Yano A; Aridome K; Kikuchi M; Kumai H; Nagano H; Okamoto K; Oda M; Sakuma S; Aikou T; Muramatsu H; Kadomatsu K; Muramatsu T
Br J Cancer; 2000 Sep; 83(6):701-6. PubMed ID: 10952771
[TBL] [Abstract][Full Text] [Related]
5. Increased midkine levels in sera from patients with Alzheimer's disease.
Salama RH; Muramatsu H; Shimizu E; Hashimoto K; Ohgake S; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Okada S; Iyo M; Muramatsu T
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):611-6. PubMed ID: 15866365
[TBL] [Abstract][Full Text] [Related]
6. Expression of the heparin-binding growth factor midkine in the cerebrospinal fluid of patients with neurological disorders.
Yoshida Y; Ikematsu S; Muramatsu H; Sakakima H; Mizuma N; Matsuda F; Sonoda K; Umehara F; Ohkubo R; Matsuura E; Goto M; Osame M; Muramatsu T
Intern Med; 2008; 47(2):83-9. PubMed ID: 18195496
[TBL] [Abstract][Full Text] [Related]
7. Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia.
Fu YY; Zhang T; Xiu MH; Tang W; Han M; Yun LT; Chen DC; Chen S; Tan SP; Soares JC; Tang WJ; Zhang XY
Schizophr Res; 2016 Oct; 176(2-3):196-200. PubMed ID: 27237600
[TBL] [Abstract][Full Text] [Related]
8. Altered serum levels of vascular endothelial growth factor in first-episode drug-naïve and chronic medicated schizophrenia.
Ye F; Zhan Q; Xiao W; Tang X; Li J; Dong H; Sha W; Zhang X
Psychiatry Res; 2018 Jun; 264():361-365. PubMed ID: 29677618
[TBL] [Abstract][Full Text] [Related]
9. High levels of urinary midkine in various cancer patients.
Ikematsu S; Okamoto K; Yoshida Y; Oda M; Sugano-Nagano H; Ashida K; Kumai H; Kadomatsu K; Muramatsu H; Takashi Muramatsu ; Sakuma S
Biochem Biophys Res Commun; 2003 Jun; 306(2):329-32. PubMed ID: 12804566
[TBL] [Abstract][Full Text] [Related]
10. Serum midkine concentrations and gastric cancer.
Obata Y; Kikuchi S; Lin Y; Yagyu K; Muramatsu T; Kumai H;
Cancer Sci; 2005 Jan; 96(1):54-6. PubMed ID: 15649256
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus.
Wu GC; Yuan H; Pan HF; Ye DQ
Oncotarget; 2017 Jun; 8(25):40181-40189. PubMed ID: 27903979
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas.
Muramatsu H; Song XJ; Koide N; Hada H; Tsuji T; Kadomatsu K; Inui T; Kimura T; Sakakibara S; Muramatsu T
J Biochem; 1996 Jun; 119(6):1171-5. PubMed ID: 8827454
[TBL] [Abstract][Full Text] [Related]
13. Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients.
Soulié P; Héroult M; Bernard-Pierrot I; Caruelle D; Oglobine J; Barritault D; Courty J
Cancer Detect Prev; 2004; 28(5):319-24. PubMed ID: 15542254
[TBL] [Abstract][Full Text] [Related]
14. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
Oncol Rep; 2003; 10(2):411-4. PubMed ID: 12579281
[TBL] [Abstract][Full Text] [Related]
15. Circulating midkine in children with Henoch-Schönlein purpura: Clinical implications.
Su Z; Lv X; Liu Y; Zhang J; Guan J; Gai Z
Int Immunopharmacol; 2016 Oct; 39():246-250. PubMed ID: 27497193
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of Midkine in children and adolescents without malignant disease.
Lucas S; Henze G; Schnabel D; Barthlen W; Sakuma S; Kurtz A; Driever PH
Pediatr Int; 2010 Feb; 52(1):75-9. PubMed ID: 19460128
[TBL] [Abstract][Full Text] [Related]
17. Quantitative comparison of immunohistochemical and PCR analysis of midkine expression in breast cancer types and serum midkine level.
Çetin Sorkun H; Akbulut M; Enli Y; Tepeli E; Özkan S; Erdem E
Turk J Med Sci; 2016 Jan; 46(1):219-27. PubMed ID: 27511357
[TBL] [Abstract][Full Text] [Related]
18. Immunoassay for measuring the heparin-binding growth factors HARP and MK in biological fluids.
Soulié P; Héroult M; Bernard I; Kerros ME; Milhiet PE; Delbé J; Barritault D; Caruelle D; Courty J
J Immunoassay Immunochem; 2002; 23(1):33-48. PubMed ID: 11848100
[TBL] [Abstract][Full Text] [Related]
19. Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis.
Maruyama K; Muramatsu H; Ishiguro N; Muramatsu T
Arthritis Rheum; 2004 May; 50(5):1420-9. PubMed ID: 15146411
[TBL] [Abstract][Full Text] [Related]
20. Increased serum midkine levels in autism spectrum disorder patients.
Esnafoglu E; Cirrik S
Int J Neurosci; 2018 Jul; 128(7):677-681. PubMed ID: 29164967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
